KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Other Non-Current Liabilities (2020 - 2026)

AbCellera Biologics filings provide 7 years of Other Non-Current Liabilities readings, the most recent being $11.3 million for Q1 2026.

  • Quarterly Other Non-Current Liabilities rose 597.11% to $11.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $11.3 million through Mar 2026, up 597.11% year-over-year, with the annual reading at $13.9 million for FY2025, 93.65% up from the prior year.
  • Other Non-Current Liabilities hit $11.3 million in Q1 2026 for AbCellera Biologics, down from $13.9 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $30.6 million in Q1 2022 and bottomed at $1.4 million in Q3 2025.
  • Average Other Non-Current Liabilities over 5 years is $6.6 million, with a median of $5.1 million recorded in 2023.
  • Peak annual rise in Other Non-Current Liabilities hit 3189.26% in 2022, while the deepest fall reached 93.64% in 2022.
  • AbCellera Biologics' Other Non-Current Liabilities stood at $3.1 million in 2022, then soared by 91.38% to $5.9 million in 2023, then grew by 21.39% to $7.2 million in 2024, then skyrocketed by 93.65% to $13.9 million in 2025, then decreased by 18.45% to $11.3 million in 2026.
  • Per Business Quant, the three most recent readings for ABCL's Other Non-Current Liabilities are $11.3 million (Q1 2026), $13.9 million (Q4 2025), and $1.4 million (Q3 2025).